Gene: PRRT2
Official Full Name: proline rich transmembrane protein 2provided by HGNC
Gene Summary: This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30950 | PRRT2 Knockout cell line (HeLa) | Human | PRRT2 | 1:3~1:6 | Negative | Online Inquiry |
KO30951 | PRRT2 Knockout cell line (HCT 116) | Human | PRRT2 | 1:2~1:4 | Negative | Online Inquiry |
KO30952 | PRRT2 Knockout cell line (HEK293) | Human | PRRT2 | 1:3~1:6 | Negative | Online Inquiry |
PRRT2 Gene Knockout Cell Lines are genetically modified cell lines specifically constructed to lack the expression of the PRRT2 gene, which plays a critical role in neuronal signaling and has been implicated in several neurological disorders. These cell lines serve as essential tools for researchers aiming to dissect the physiological roles of PRRT2 and its implications in synaptic transmission and seizure disorders.
The key function of PRRT2 is related to its involvement in regulating neurotransmitter release, and its knockout facilitates the study of its absence in various cellular contexts. The mechanisms by which these cell lines exhibit altered behavior can be analyzed through electrophysiological studies, calcium imaging, and other molecular assays that elucidate the pathways affected by the absence of PRRT2. This comprehensive understanding is crucial for delineating the gene's role in pathophysiological conditions such as epilepsy and movement disorders.
In terms of scientific importance, PRRT2 Gene Knockout Cell Lines offer invaluable resources for both basic and translational research. Their utilization can significantly expedite the discovery of therapeutic targets, contributing to the development of novel interventions for conditions where PRRT2 is implicated. Researchers in neuroscience, pharmacology, and genetics can leverage these cell lines to validate hypotheses and explore disease mechanisms, ultimately enhancing our understanding of synaptic pathology.
What sets these cell lines apart from alternatives is their precise genetic modification, ensuring reliable and reproducible results. Unlike transient expression systems or pharmacological inhibition methods, the knockout approach allows for the stable study of long-term effects, making them a superior choice for rigorous investigative studies.
These PRRT2 Gene Knockout Cell Lines represent a vital asset for researchers and clinicians committed to unlocking the complexities of neurological diseases. The strategic insights gained from using these models can lead to groundbreaking advancements in therapeutic strategies and improved patient outcomes.
At [Your Company Name], we pride ourselves on our expertise in providing high-quality biological products that empower researchers in their quest for scientific discovery. Our commitment to innovation and excellence ensures that our offerings remain at the forefront of scientific research and applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.